StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Stand-off

<< Previous

Bullboard Posts

Next >>

Comment by brad129on Jan 31, 2022 9:47pm

139 Views

Post# 34382974

RE:RE:RE:RE:Stand-off

when your market cap is low enough, it really wouldn't take much for any corporation(acquisition, buyout, or to downplay the tech, competitor) could manipulate doesn't take much skin, for whatever the reason it's being manipulated, others are trying to develop what we have, there is a reason for that.

by the way down to 13 appointments left this week, also note multiple people can be on one call, I know once I receive real world data the test will be ordered not only for myself but my wife as well.